Umoja wa Ulaya - Kiestonia - EMA (European Medicines Agency)

dechra regulatory b.v. - mirtazapine - psychoanaleptics, antidepressants in combination with psycholeptics - kassid - näiteks kehakaalu suurenemine kassid tekkinud isutus ja kaalu kaotus, mis tulenevad kroonilised haigusseisundid.

Umoja wa Ulaya - Kiestonia - EMA (European Medicines Agency)

novartis europharm limited - brinsolamiidi, brimonidine tartraat - ocular hypertension; glaucoma, open-angle - oftalmoloogilised vahendid - kõrge silmasisese rõhu (iop) vähenemine avatud nurga glaukoomi või okulaarse hüpertensiooniga täiskasvanud patsientidel, kellel monoteraapia annab iop-i vähesuse.

Umoja wa Ulaya - Kiestonia - EMA (European Medicines Agency)

virbac s.a. - clomipramine hydrochloride - psühhoanaleptikumid - koerad - as an aid in the treatment of separation related disorders in dogs manifested by destruction and inappropriate elimination (defecation and urination) and only in combination with behavioural modification techniques.

Umoja wa Ulaya - Kiestonia - EMA (European Medicines Agency)

janssen-cilag international nv - esketamine vesinikkloriid - depressiivne häire - teised antidepressandid - spravato, koos ssri või snri, on näidustatud täiskasvanute raviks ravimresistentse depressiooniga, kes ei ole vastanud vähemalt kaks erinevat ravi koos antidepressantidega praeguse mõõduka kuni raske depressiivne episood.

Umoja wa Ulaya - Kiestonia - EMA (European Medicines Agency)

bial portela & companhia s.a. - opikapoon - parkinsoni tõbi - parkinsoni tõve ravimid - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.

Umoja wa Ulaya - Kiestonia - EMA (European Medicines Agency)

janssen-cilag international n.v. - darunavir, cobicistat - hiv-nakkused - antivirals for systemic use, antivirals for treatment of hiv infections, combinations - rezolsta on näidustatud koos teiste retroviirusevastaste ravimitega inimese immuunpuudulikkuse viiruse 1 (hiv 1) nakkuse raviks 18-aastastel ja vanematel täiskasvanutel. genotypic katsetamine peaks juhendi kasutamine rezolsta.

Umoja wa Ulaya - Kiestonia - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - ravimid hingamisteede obstruktiivsete haiguste, - asthma biresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdbiresp spiromax is indicated in adults, aged 18 years and older, for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

Umoja wa Ulaya - Kiestonia - EMA (European Medicines Agency)

teva pharma b.v. - budesonide, formoterol fumarate dihydrate - pulmonary disease, chronic obstructive; asthma - ravimid hingamisteede obstruktiivsete haiguste, - asthma duoresp spiromax is indicated in adults and adolescents (12 years and older) for the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β₂ adrenoceptor agonist) is appropriate:in patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β₂ adrenoceptor agonists. orin patients already adequately controlled on both inhaled corticosteroids and long-acting β₂ adrenoceptor agonists. copdduoresp spiromax is indicated in adults, aged 18 years and older for the symptomatic treatment of patients with copd with forced expiratory volume in 1 second (fev₁).

Umoja wa Ulaya - Kiestonia - EMA (European Medicines Agency)

ucb pharma s.a.   - fenfluramine hydrochloride - epilepsies, myoclonic - antiepileptics, - treatment of seizures associated with dravet syndrome as an add-on therapy to other antiepileptic medicines for patients 2 years of age and older. fintepla is indicated for the treatment of seizures associated with dravet syndrome and lennox-gastaut syndrome as an add-on therapy to other anti-epileptic medicines for patients 2 years of age and older.

Umoja wa Ulaya - Kiestonia - EMA (European Medicines Agency)

janssen-cilag international nv - rilpivirine - hiv-nakkused - viirusevastased ravimid süsteemseks kasutamiseks - rekambys is indicated, in combination with cabotegravir injection, for the treatment of human immunodeficiency virus type 1 (hiv 1) infection in adults who are virologically suppressed (hiv-1 rna < 50 copies/ml) on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with, agents of the nnrti and ini class.